Detalhe da pesquisa
1.
Anemia-related response end points in myelofibrosis clinical trials: current trends and need for renewed consensus.
Future Oncol
; 20(11): 703-715, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38318719
2.
Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib.
Haematologica
; 109(2): 676-681, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37259556
3.
Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trial.
Leuk Lymphoma
; : 1-13, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38501751
4.
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis.
EJHaem
; 5(1): 105-116, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38406514
5.
Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis.
Leukemia
; 36(9): 2261-2268, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869266
6.
Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC.
J Thorac Oncol
; 14(12): 2152-2163, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31470128
7.
Regulation of Gene Editing Activity Directed by Single-Stranded Oligonucleotides and CRISPR/Cas9 Systems.
PLoS One
; 10(6): e0129308, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26053390
8.
The position of DNA cleavage by TALENs and cell synchronization influences the frequency of gene editing directed by single-stranded oligonucleotides.
PLoS One
; 9(5): e96483, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24788536
9.
Combinatorial gene editing in mammalian cells using ssODNs and TALENs.
Sci Rep
; 4: 3791, 2014 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24445749
10.
Electrospun fiber membranes enable proliferation of genetically modified cells.
Int J Nanomedicine
; 8: 855-64, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23467983
11.
DNA damage response pathway and replication fork stress during oligonucleotide directed gene editing.
Mol Ther Nucleic Acids
; 1: e18, 2012 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23343929
12.
Oligonucleotide delivery by nucleofection does not rescue the reduced proliferation phenotype of gene-edited cells.
Nucleic Acid Ther
; 22(6): 405-13, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23072627
13.
Proliferation of genetically modified human cells on electrospun nanofiber scaffolds.
Mol Ther Nucleic Acids
; 1: e59, 2012 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23212298